About Us
   Programs
   Results
   Mission/Vision
   Leadership

Support Us

Research Awards
   About
   Impact
   Award Recipients
   Apply for an Award

Collaboration
   Clinical Network
   Preclinical Screening
   Industry

News Room
   What's New
   Advance Newsletter
   Releases
   In the News
   Media Kit

Resources/Information
   Learn from the Experts
   Statistics
   Clinical Trials
   Additional Resources

Contact Us

Home

Project Awards

2005

Investigator Institution Project

Cameron Brennan, MD

 

Memorial Sloan-Kettering Cancer Center

 

Identification of fusion kinases as potential therapeutic targets in malignant astrocytoma and oligodendroglioma including malignant glioma

Alan D'Andrea, MD

 

Dana-Farber Cancer Institute

 

Inhibitors of the fanconi anemia Pathway as Chemosensitizing Agents for 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU) in the Treatment of Brain Tumors

Ingo Mellinghoff, MD

 

University of California Los Angeles

 

A Genome-Wide View of mTOR Dependence in GBM

Paul Mischel, MD

 

Univerisity of California Los Angeles

 

Development of a microPLC for molecular diagnosis of Glioblastoma

Jeremy Rich, MD

 

Duke University

 

Targeting DNA Damage Checkpoint Signaling in Glioma Radioresistance

Axel Schönthal, PhD

 

University of Southern California

 

Flouting COX-2: Applying the COX-2-Independent Anti-Tumor Efficacy of Celebrex to the Therapy of Glioblastoma

Angela van Tilborg, PhD

 

University of Amsterdam

 

Protein kinase target profiling and ex vivo target validation to identify efficacious inhibitors for malignant glioma

WK Alfred Yung, MD

 

University of Texas/MD Anderson Cancer Center

 

Evaluation of Small Molecule Inhibitors of the P13K/AKT Pathway

 
Content copyright © 2008 Accelerate Brain Cancer Cure, Inc.